(Q44164288)

30 November 2017

A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines (English)

1 reference

30 November 2017

0 references

1 reference

1 reference

1

1 reference

30 November 2017

8

1 reference

30 November 2017

10

Robert W Sauerwein

1 reference

30 November 2017

Vasee S Moorthy

13

0 references

Kirsten E Lyke

6

object named as

Kirsten E Lyke

1 reference

30 November 2017

Christian F Ockenhouse

7

object named as

Christian F Ockenhouse

1 reference

30 November 2017

9

Meta Roestenberg

1 reference

30 November 2017

4

Adrian V Hill

1 reference

30 November 2017

11

Michele D Spring

1 reference

30 November 2017

5

Jack L Komisar

1 reference

30 November 2017

Christopher J Duncan

2

1 reference

30 November 2017

Judith E Epstein

3

1 reference

30 November 2017

Angela K Talley

12

1 reference

30 November 2017

Consensus Group on Design of Clinical Trials of Controlled Human Malaria Infection

14

1 reference

30 November 2017

language of work or name

English

0 references

publication date

31 May 2012

1 reference

30 November 2017

1 reference

30 November 2017

30

1 reference

30 November 2017

36

1 reference

30 November 2017

5302-5304

1 reference

Experimental human challenge infections can accelerate clinical malaria vaccine development

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.088

Protection against a malaria challenge by sporozoite inoculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.088

The RTS,S malaria vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.088

Malaria transmitted to humans by mosquitoes infected from cultured plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.088

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.088

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.088

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.088

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.088

Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.088

10.1016/J.VACCINE.2012.04.088

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference